Biomaterials and scaffolds in bone and musculoskeletal engineering

Current Stem Cell Research and Therapy

Volumn 8, Issue 3, 2013, Pages 185-191

  Kosuge, Dennis ^a   Khan, Wasim S ^b   Haddad, Behrooz ^b   Marsh, David ^b  

^a ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biomaterials; Orthopaedics; Scaffolds; Tissue engineering

Indexed keywords

BIOCERAMICS; BIOMATERIAL; CHITOSAN; COLLAGEN; FIBRIN; HYALURONIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; TISSUE SCAFFOLD;

ARTICLE; ARTICULAR CARTILAGE; BIOCOMPATIBILITY; BONE REGENERATION; BONE TRANSPLANTATION; COMPOSITE MATERIAL; DEGRADATION; ELECTROSPINNING; IMMUNE RESPONSE; NANOTECHNOLOGY; NONHUMAN; PHASE SEPARATION; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE REPAIR;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; HUMANS; MUSCULOSKELETAL SYSTEM; NANOTECHNOLOGY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84876728285     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308030002     Document Type: Article

References (99)

1. Vijayan S, Bartlett W, Bentley G, et al. Autologous chondrocyte implantation for osteochondral lesions in the knee using a bilayer collagen membrane and bone graft: a two-to eight-year follow-up study. J Bone Joint Surg Br 2012; 94(4): 488-492.
2. Hollister SJ, Murphy WL. Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev 2011; 17(6): 459-474.
3. Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996; 17(2): 103-114.
4. Gilbert TW, Stewart-Akers AM, Badylak SF. A quantitative method for evaluating the degradation of biologic scaffold materials. Biomaterials 2007; 28: 147-150.
5. Mastrogiancomo M, Scaglione S, Martinetti R, et al. Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials 2006; 27(17): 3230-3237.
6. Gomes M, Holtorf H, Reis R, Mikos AG. Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng 2006; 12(4): 801-809.
7. Zhang Y, Zhang M. Three-dimensional macroporous calcium phosphate bioceramics with nested chitosan sponges for loadbearing bonne implants. J Biomed Mater Res 2002; 61(1): 1-8.
8. Lewandrowski KU, Gresser JD, Bondre S, Silva AE, Wise DL, Trantolo DJ. Developing porosity of poly(propylene glycol-cofumaric acid) bone graft substitutes and the effect of osteointegration: a preliminary histology study in rats. J Biomater Sci Polym Ed 2000; 11(8): 879-889.
9. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000; 21(24): 2529-2543
10. Hynes RO, Zhao Q. The evolution of cell adhesion. J Cell Biol 2000; 150(2): F89-F96.
11. Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 1996; 17(2): 137-146.
12. Bell BF, Schuler M, Tosatti S, et al. Osteoblast response to titanium surfaces functionalized with extracellular matrix peptide biomimetics. Clin Oral Implants Res 2011; 22(8): 865-872.
13. Chen YW, Chiou SH, Wong TT, et al. Using gelatin scaffold with coated basic fibroblast growth factor as a transfer system for transplantation of human neural stem cells. Transplant Proc 2006; 38(5): 1616-1617.
14. Hollister SJ, Maddox RD, Taboas JM. Optimal design and fabrication of scaffolds to mimic tissue properties and satisfy biological constraints. Biomaterials 2002; 23(20): 4095-4103.
15. Hamilton L, France RM, Shakesheff KM. Development of an injectable scaffold for application in regenerative medicine to deliver stem cells and growth factors. J Pharm Pharmacol 2008; 58: A52-A53.
16. Hidalgo-Bastida LA, Barry JJ, Everitt NM, et al. Cell adhesion and mechanical properties of a flexible scaffold for cardiac tissue engineering. Acta Biomater 2007; 3: 457-462.
17. Fridrikh SV, Yu JH, Brenner MP, Rutledge GC. Controlling the fiber diameter during electrospinning. Phys Rev Lett 2003; 90(14): 144502-1, 144502-144504.
18. Reneker DH, Chun I. Nanometre diameter fibres of polymer, produced by electrospinning. Nanotechnology 1996; 7(3): 216-223.
19. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001; 294(5547): 1684-1688.
20. Hartgerink JD, Beniash E, Stupp SI. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proc Natl Acad Sci USA 2002; 99(5): 133-138.
21. Zhang R, Ma PX. Processing of polymer scaffolds: phase separation. In Atala A, Lanza RP(eds). 2002. Methods of tissue engineering. San Diego: Academic Pr, p715-124.
22. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989; 3: 192-195
23. Azevedo HS, Gama FM, Reis RL. In vitro assessment of the enzymatic degradation of severel starch based biomaterials. Biomacromolecules 2003; 4(6): 1703-1712.
24. Varum K, Myhr M, Hjerde R, Smidsrod O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr Res 1997; 299(1-2): 99-101.
25. He Q, Zhao Y, Chen B, et al. Improved cellularization and angiogenesis using collagen scaffolds chemically conjugated wiith vascular endothelial growth factor. Acta Biomater 2011; 7: 1084-1093
26. Cao H, Chen X, Huang L, Shao Z. Electrospinning of reconstituted silk fiber from aqueous silk fibroin solution. Mater Sci Eng C 2009; 29: 2270-2274.
27. Yilgor P, Tuzlakoglu K, Reis RL, et al. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009; 30: 3551-3559.
28. Mendes S, Reis R, Bovell Y, Cunha A, Van Blitterswijk CA, de Bruijn J. Biocompatibility testing of novel starch-based materials with potential application in orthopaedic surgery: a preliminary study. Biomaterials 2001; 22(14): 2057-2064.
29. Abbah S, Lu W, Chan D, et al. Osteogenic behavior of alginate encapsulated bone marrow stromal cells: An in vitro study. J Mater Sci Mater Med 2008; 19(5): 2113-2119.
30. Bakos D, Soldan M, Hernandez-Fuente I. Hydroxyapatite-collagenhyaluronic acid composite. Biomaterials 1999; 20(2): 191-195.
31. Shields KJ, Beckman MJ, Bowlin GL, Wayne JS. Mechanical properties and cellular proliferation of electrospun collagen type II. Tissue Eng 2004; 10(9-10): 1510-1517.
32. Cen L, Liu W, Cui L, Zhang W, Cao Y. Collagen Tissue Engineering: Development of novel biomaterials and applications. Pediatr Res 2008; 63(5): 492-496.
33. Glowacki J, Mizuno S. Collagen scaffolds for tissue engineering. Biopolymers 2008; 89(5): 338-344.
34. Mizuno S, Glowacki J. Three-dimensional composite of demineralized bone powder and collagen for in vitro analysis of chondroinduction of human dermal fibroblasts. Biomaterials 1996; 17(18): 1819-1825.
35. Marcacci M, Berruto M, Brocchetta D, el al. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res 2005; 435: 96-105.
36. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, Williams DF. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 1998; 19: 2101-2127.
37. Tognana E, Borrione A, De Luca C, Pavesio A. Hyalograft C: hyaluronan-based scaffolds in tissue-engineered cartilage. Cells Tissues Organs 2007; 186(2): 97-103.
38. Nehrer S, Domayer S, Dorotka R, Schatz K, Bbindreiter U, Kotz R. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 2006; 57(1): 3-8
39. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci 2001; 936: 11-30.
40. Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008; 14(2): 199-215.
41. Ito K, Yamada Y, Naiki T, Ueda M. Simultaneous implant placement and bone regeneration around dental implants using tissueengineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res 2006; 17(5): 579-586.
42. Zhu SJ, Choi BH, Jung JH, et al. A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and plateletenriched fibrin glue. Oral Surg Oral Med Oral Pathol Oral Radiol Endol 2006; 102(2): 175-179.
43. Singh K, Moyer H, Williams JK, Schwartz Z, Boyan BD. Fibrin glue: a scaffold for cellular-based therapy in a crtical-sized defect. Ann Plast Surg 2011; 66(3): 301-305.
44. Piontek T, Ciemniewska-Gorzela K, Szulc A, Naczk J, Siomczykowski M. All-arthroscopic AMIC procedure for repair of cartilage defects of the knee. Knee Surg Sports Traumatol Arthrosc 2012; 20(5): 922-925.
45. Nehrer S, Chiari C, Domayer S, Barkay H, Yayon A. Results of chondrocyte implantation with a fibrin-hyaluronan matrix: a preliminary study. Clin Orthop Relat Res 2008; 466(8): 1849-1855.
46. Di Martino A, Sittinger M, Risbud MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005; 26(30): 5983-5990.
47. Muzzarelli R, Tarsi R, Filippini O, Giovanetti E, Biangini G, Varaldo PE. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob Agents Chemother 1990; 34(10): 2019-2023.
48. Ueno H, Yamada H, Tanaka I, et al. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials 1999; 20(15): 1407-1414.
49. Yin Y, Ye F, Cui J, Zhang F, Li X, Yao K. Preparation and characterization of macroporous chitosan-gelatin/beta-tricalcium phosphate composite scaffolds for bone tissue engineering. J Biomed Mater Res A 2003; 67(3): 844-855.
50. Maruyama M, Ito M. In vitro properties of a chitosan-bonded selfhardening paste with hydroxyapatite granules. J Biomed Mater Res 1996; 32(4): 527-532.
51. Yeo YJ, Jeon DW, Kim CS, et al. Effects of chitosan nonwoven membrane on periodontal healing of surgically reated one-wall intrabony defects in beagle dogs. J Biomed Mater Res B Appl Biomater 2005; 72(1): 86-93.
52. Muzzarelli R, Baldassarre V, Conto F, et al. Biological activity of chitosan: ultrastructural study. Biomaterials 1988; 9(3): 247-252.
53. Ma PX, Langer R. Morphology and mechanical function of longterm in vitro engineered cartilage. J Biomed Mater Res 1999; 44: 217-221.
54. Li WJ, Jiang YJ, Tuan RS. Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng 2006; 1: 1775-1785.
55. Roh JD, Brennan MP, Lopez-Soler RI, et al. Construction of an autologous tissue-engineered venous conduit from bone marrowderived vascular cells: optimization of cell harvest and seeding techniques. J Pediatr Surg 2007; 42: 198-202.
56. Horstmann WG, Verheyen CC, Leemans R. An injectable calcium phosphate cement as a bone-graft substitute in the treatment of displaced lateral plateau fractures. Injury 2003; 34: 141-144.
57. Kelly CM, Wilkins RM, Gitelis S, et al. The use of a surgical grade calcium sulphate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res 2001; 382: 42-50.
58. Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury 2000; 31: D37-D47.
59. Bucholz RW, Carton A, Holmes RE. Hydroxyapatite and tricalcium phosphate bone graft substitutes. Orthop Clin North Am 1987; 18: 323-334.
60. Truumees E, Herkowitz HN. Alternatives to autologous bone harvest in spine surgery. Univ Pen Orthop J 1999; 12: 77-88.
61. Manzotti A, Confalonieri N, Pullen C. Grafting of tibial bone defects in knee replacement using Norian skeletal repair system. Arch Orthop Trauma Surg 2006; 126(9): 594-598.
62. Hammouche S, Khan W, Drouin H, Procter H, McNicholas M. Calcium salts bone regeneration scaffolds: a review article. Curr Stem Cell Res Ther 2012; 7(5): 336-346.
63. Montjovent MO, Matheiu L, Schmoekel H, et al. Repair of critical size defects in the rat cranium using ceramic-reinforced PLA scaffolds obtained by supercritical gas foaming. J Biomed Mater Res A 2007; 83(1): 41-51.
64. Namikawa T, Terai H, Suzuki H, et al. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine (Phila Pa 1976) 2005; 30(15)1717-1722.
65. Schaefer D, Martin I, Shastri P, et al. In vitro generation of osteochondral composites. Biomaterials 2000; 21(24): 2599-2606
66. Liu Y, Chen F, Liu W, et al. Repairing large porcine full-thickness defects of articular cartilage using autologous chondrocyteengineered cartilage. Tissue Eng 2002; 8: 709-721.
67. Zhou G, Liu W, Cui L, Wang X, Liu T, Cao Y. Repair of porcine articular osteochondral defects in non-weight bearing areas with autologous bone marrow stromal cells. Tissue Eng 2006; 12: 3209-3221.
68. Böstmann O, Hirvensalo E, Mäkinen J, Rokkanen P. Foreign body reactions to fracture fixation implants of biodegradable synthetic polymers. J Bone Joint Surg Br 1990; 72(4): 592-596.
69. Bergsma EJ, Brujn W, Rozema FR, Bos RM, Boering G. Late tissue response to poly(L-lactide) bone plates and screws. Biomaterials 1995; 16(1): 25-31.
70. Du C, Cui FZ, Zhu XD, deGroot K. Three-dimensional nano-HAp/collagen matrix loading with osteogenic cells in organ culture. J Biomed Mater Res 1999; 44: 407-415.
71. Li Z, Yubao L, Aiping Y, Xuelin P, Xuejiang W, Xiang Z. Preparation and in vitro investigation of chitosan/nano-hydroxyapatite composite used as bone substitute materials. J Mater Sci: Mater Med 2005; 16(3): 213-219
72. Liao SS, Cui FZ, Zhang W, Feng QL. Hierarchically biomimetic bone scaffold materials: Nano-HA/collagen/PLA composite. J Biomed Mater Res B: Appl Biomat 2004; 69B: 158-165
73. Agrawal CM, Athanasiou KA. Techniques to control pH in vicinity of biodegrading PLA-PGA implants. J Biomed Mater Res Appl Biomater 1997; 38(2): 105-114.
74. Shikinami Y, Okuno M. Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly-L-lactide (PLLA): part I. Basic characteristics. Biomaterials 1998; 20:859-877.
75. Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy 2003; 19(5): 477-484.
76. Hangody L, Fules P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am 2003; 85 Suppl 2: 25-32.
77. Vijayan S, Bartlett W, Bentley G, et al. Autologous chondrocyte implantation for osteochondral lesions in the knee using a bilayer collagen membrane and bone graft: a two-to eight-year follow-up study. J Bone Joint Surg Br 2012; 94(4):488-492.
78. Gooding CR, Bartlett W, Bentley G, et al. A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: periosteum covered versus type I/III collagen covered. Knee 2006; 13: 203-210.
79. Nehrer S, Dorotka R, Domayer S, Stelzeneder D, Kotz R. Treatment of full-thickness chondral defects with hyalograft C in the knee: a prospective clinical case series with 2 to 7 years' followup. Am J Sports Med 2009; 37 Suppl 1: 81S-87S.
80. Ma PX, Langer R. Morphology and mechanical function of longterm in vitro engineered cartilage. J Biomed Mater Res 1999; 44: 217-221.
81. Li WJ, Jiang YJ, Tuan RS. Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng 2006; 12: 1775-1785.
82. Ko HF, Sfeir C, Kumta PN. Novel synthesis strategies for natural polymer and composite biomaterials as potential scaffolds for tissue engineering. Philos Transact A Math Phys Eng Sci 2010; 368: 1981-1997.
83. Capito RM, Spector M. Scaffold-based articular cartilage repair. IEEE Eng Med Biol Mag 2003; 22: 2-50
84. Marmotti A, Bruzzone M, Bonasia DE, et al. One-step osteochondral repair with cartilage fragments in a composite scaffold. Knee Surg Sports Traumatol Arthrosc 2012; 20(12): 2590-2601.
85. Goulet JA, Senunas LE, DeSilva GL, Greenfield ML. Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res 1997; 339: 76-81.
86. Wolff J. Das gesetz der transformation der knochen. Berlin: Verlag von August Hirschwald; 1892
87. Bauer TW, Muschler GF. Bone graft materials: an overview of the basic science. Clin Orthop 2000; 371: 10-27.
88. Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010; 31: 6279-6308.
89. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213: 341-347.
90. Petite H, Viateau V, Bensaïd W, et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18(9): 959-963.
91. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344: 385-386.
92. Vunjak-Novakovic G, Altman G, Horan R, Kaplan DL. Tissue engineering of ligaments. Annu Rev Biomed Eng 2004; 6: 131-156.
93. Garvin J, Qi J, Maloney M et al. Novel system for engineering bioartificial tendons and application of mechanical load. Tissue Eng 2003; 9: 967-979.
94. Juncosa-Melvin N., Shearn JT, Boivin GP, et al. Effects of mechanical stimulation on the biomechanics and histology of stem cell-collagen sponge constructs for rabbit patellar tendon repair. Tissue Eng 2006; 12: 2291-2300.
95. Cao Y, Liu Y, Liu W, Shan Q, Buonocore SD, Cui L. Bridging tendon defects using autologous tenocyte engineered tendon in a hen model. Plast Reconstr Surg 2002; 110: 1280-1289.
96. McCulloch PC, Lattermann C, Boland AL, Bach BR Jr. An illustrated history of anterior cruciate ligament surgery. J Knee Surg 2007; 20(2): 95-104.
97. Cooper JA, Lu HH, Ko FK, Freeman JW, Laurencin CT. Fiberbased tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation. Biomaterials 2005; 26: 1523-1532.
98. Fairbanks T. Knee joint changes after menisectomy. J Bone Joint Surg Br 1948; 30: 664-670.
99. Kon E, Filardo G, Tschon M, et al. Tissue engineering for total meniscal substitution: animal study in sheep model-results at 12 months. Tissue Eng Part A 2012; 18(15-16): 1573-1582.